Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03835429 · ClinicalTrials.gov registry record · NA
Effect of Oral Appliance Therapy on Atrial Fibrillation
A NA study, sponsored by Texas A&M University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03835429 is a NA study that was terminated before completion, run by Texas A&M University. The registered enrollment target is 3 participants.
The verdict
NCT03835429, a NA study, was terminated before completion, sponsored by Texas A&M University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This pilot study is expected to determine the efficacy of using the midline traction designed MyTAP plus mouth shield (MyTAP + MS) oral appliance combination in decreasing the number of Atrial Fibrillation events. The MS is a patient comfort accessory to the MyTAP.
Interventions
- DEVICE MyTAP oral appliance plus mouth shield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-01-15 |
| Est. Completion | 2025-01-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03835429
The ClinicalTrials.gov registry entry for NCT03835429 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MyTAP oral appliance plus mouth shield is the first listed.
NCT03835429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03835429 about?
NCT03835429 is a clinical study titled "Effect of Oral Appliance Therapy on Atrial Fibrillation". This pilot study is expected to determine the efficacy of using the midline traction designed MyTAP plus mouth shield (MyTAP + MS) oral appliance combination in decreasing the number of Atrial Fibrillation events. The MS is a patient comfort accessory to the MyTAP.
What is the current status of trial NCT03835429?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2019-01-15. Estimated completion is 2025-01-03.
What interventions are being tested in trial NCT03835429?
The interventions under investigation include: MyTAP oral appliance plus mouth shield (DEVICE).
Who is sponsoring clinical trial NCT03835429?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.